InMode (INMD) vs Integer (ITGR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Integer (ITGR) has outperformed InMode (INMD) over the past year, gaining 22.0% versus a loss of 6.8%. Over five years, ITGR leads with a +41.8% price change compared with -83.2% for INMD. Integer is the larger company by market cap ($4.30 billion vs $806.2 million), about 5.3 times the size.
On valuation, InMode trades at a lower forward P/E (10.2x vs 18.4x for Integer).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INMD | ITGR |
|---|---|---|
| Share price | $14.01 | $126.59 |
| Market cap | $806.19M | $4.30B |
| 1-day change | +0.14% | +0.09% |
| YTD return | -4.63% | +61.41% |
| 1-year return | -6.79% | +22.05% |
| 5-year return | -83.20% | +41.79% |
| P/E ratio (TTM) | 11.58 | 34.59 |
| Forward P/E | 10.21 | 18.43 |
| EPS (TTM) | $1.21 | $3.66 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $1.85B |
| Revenue growth (YoY) | — | +7.98% |
| Net income (latest FY) | — | $102.81M |
| Gross margin | — | 26.99% |
| Operating margin | — | 11.94% |
| Net margin | — | 5.55% |
| 52-week high | $16.74 | $126.80 |
| 52-week low | $12.72 | $62.00 |
| Distance from 52-week high | -16.31% | -0.17% |
| Analyst consensus | none | none |
| Avg. price target upside | +15.42% | -3.78% |
| Average volume | 522.14K | 986.14K |
| Shares outstanding | 57.54M | 34.00M |
| Employees | 660 | 11,000 |
| Sector | Healthcare | Health Care |
| Industry | Medical Devices | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Integer is about 5.3 times larger than InMode by market value ($4.30B vs $806.19M).
- ITGR has outperformed INMD by 28.8 percentage points over the past year.
- Integer trades at a higher earnings multiple (34.6x vs 11.6x trailing P/E).
- The two companies sit in different sectors: InMode in Healthcare and Integer in Health Care.
About InMode
INMD stock →InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
Healthcare · Medical Devices · 660 employees
About Integer
ITGR stock →Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 11,000 employees
INMD vs ITGR FAQ
Which is bigger, InMode or Integer?
Integer (ITGR) is larger, with a market capitalization of $4.30B compared with $806.19M for InMode (INMD).
Which stock has performed better over the past year, INMD or ITGR?
ITGR returned +22.05% over the past 12 months, compared with -6.79% for INMD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, INMD or ITGR?
INMD has the lower trailing P/E at 11.6, versus 34.6 for ITGR. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are InMode and Integer in the same industry?
No. InMode is in the Healthcare sector, while Integer is in Health Care.